Cell death by apoptosis plays a key role in skin development and homeostasis. Previous studies have shown that increased apoptosis characterizes several pathologic conditions affecting human skin. Thus, the pathogenesis of cutaneous diseases may involve an imbalance in the homeostatic mechanisms determining whether the death of keratinocytes will occur by terminal differentiation or apoptosis. We investigated the involvement of apoptosis in psoriasis. For this purpose, we assessed, in addition to morphology and DNA fragmentation, the expression of two putative apoptotic genes, bc1-2 and "tissue" transglutaminase, in normal and psoriatic skin. A large number of keratinocytes showing biochemical and morphologic features of cells undergoing apoptosis was observed in all the suprabasallayers of the psoriatic epidermis. The plaques from all patients analyzed showed a dramatic reduc-
Cell death by apoptosis plays a key role in skin development and homeostasis. Previous studies have shown that increased apoptosis characterizes several pathologic conditions affecting human skin. Thus, the pathogenesis of cutaneous diseases may involve an imbalance in the homeostatic mechanisms determining whether the death of keratinocytes will occur by terminal differentiation or apoptosis. We investigated the involvement of apoptosis in psoriasis. For this purpose, we assessed, in addition to morphology and DNA fragmentation, the expression of two putative apoptotic genes, bc1-2 and "tissue" transglutaminase, in normal and psoriatic skin. A large number of keratinocytes showing biochemical and morphologic features of cells undergoing apoptosis was observed in all the suprabasallayers of the psoriatic epidermis. The plaques from all patients analyzed showed a dramatic reduc-D espite the increasing number of studies, the pathogenesis of psoriasis remains unclear [1] . Cell death plays a fundamental role in skin.developmen~ and i~1 the regulation of cell numbers 111 mature epidermis [2, 3] . Cell death by apoptosis, which shares several structural and regulatory events with keratinocyte death by terminal differentiation, is active in removing excessive and abnormal cells from the epidermis [2] [3] [4] [5] . A current important topic in. skin biology is the understanding of how autonomous and/or envlro~ mental signals determine whether the death of post-mitotic keratlnocytes occurs by terminal differentiation or by apopt~SlS [4, 5] . . A large number of genetic, cellular, and biochel!llcal studies have 111-dicated that several genes must be expressed 111 a strictly regulated manner to all ow a cell to die in a way compatible with physiologic conditions [3] . According to their distinct roles within the cell death program, the ~utative apoptotic ~e~es can be classified into three different functlonal groups: permiSSive, regulatory, and effector elements [6] . A key role in the initiation of apoptosis is played by proto-oncogenes such as c{os and c-myc, as well as by the tumor suppressor gene p53 [7 -9] . The product of the b~I-2 gene [10, 11] , in association with a family of recently charactenzed related genes [12] , has emerged as a suppressi,:e e l emen~ of the ~e.ll death pr~ gram; i.e., a block ofbcl-2 expressIOn IS reqUired to Imtlate apoptosls Manuscript received March 14, 1944 ; revised June 28, 1994 ; accepted for publication August 1, 1994. . .. . . Reprint requests to: Dr. Mauro Placentllll, Department of BIOlogy, UllIversity of Rome "Tor Vergata," Via E. Carnevale, 00173 Rome, Italy.
Abbreviations: TGI, "keratinocyte" transglutaminase; tTG, "tissue" transg lutaminase; TUNEL, terminal deoxynucleotidyl transferasemediated dUTP-biotin nick end labeling. tion in the number ofbcl-2 -positive cells localized in the basal cell compartment. In contrast, the psoriatic lesions presented a marked induction in "tissue" transglutaminase, which was localized specifically to the cytoplasm of apoptotic keratinocytes. "Tissue" transglutaminase protein staining was undetectable in normal epidermis. The bcl-2 and "tissue" transglutaminase staining pattern observed in psoriasis also was found in the skin of patients affected by lichen planus. These findings indicate that these two genes are regulated in an opposite fashion in psoriatic keratinocytes undergoing apoptosis, thus confirming their antithetic role in the cascade of events leading to the establishment of the mature apoptotic phenotype. [11] . Among the genes identified recently as effector elements of the apoptotic cell death program are those coding for the Ca++-dependent enzymes "tissue" transglutaminase (tTG) and endonuclease [3, 12, 13] . Transglutaminases are a family of intracellular and extracellular enzymes that catalyze Ca++-dependent reactions establishing e(y-glutamyl)lysine bonds and/or di-and polyamines derived cross-linkages into proteins [3, 12] . The tTG gene is expressed in cells undergoing apoptosis in various in vivo and in vitro contexts [3,14,!5] . Overexpression of tTG in Balb/c 3T3 fibroblasts produces 111 the transfected cells the cytoplasmic changes characteristic of apoptosis [16] . tTG activation in the dying cells leads to the formation of intracellular protein polymers insoluble in detergents and. chaotroplc ~g~nts [3, 1 2] . Another biochemical event occurring dunng apoptosls IS cleavage of the DNA at the internucleosomal linker regions [3, 13] .
Morphologic studies have shown that an increased number of apoptotic cells characterizes several pathologic conditions affecting mature human skin, such as lichen planus, Darier's disease, "sunburn cells," graft-versus-host reactions, and tumors [2,4,5,15 -19] . In this report, we demonstrate that in psoriatic patients an abnormal bcl-2 and tTG expression, indicative of an increased apoptotic rate, parallels the typical hyperplastic syndrome.
.
MATERIALS AND METHODS
Chemicals Streptavidin-biotin immunoperoxidase staining systems were obtained from Biogcnex (San Ramon, CA). Other chemicals were of reagent grade and used without further purification. Figure 1 . Characterization of the specificity of bcl-2 expression in normal human skin. Western blotting analysis was carried out on total protein extracts (approximately 100 J.lg, latze 1, and 50 J.lg, lane 2) prepared from normal human skin and subjected to SDS-PAGE as described previously [16] . Arrows, relative positions of the molecular weight standards.
ment of Dermatology, University of Rochester). The monoclonal anti-human oncoprotein bcl-2 was purchased from Dako. The OKT6 anti-human CDl and the anti-human leukocyte antigen (HLA)-DR antibodies were obtained from Ortho Diagnostic (Milano, Italy).
Skin Biopsies Human skin biopsy specimens were obtained from five chronic plaque-type untreated psoriatic patients and quickly placed into the fixative fluid (Bouin's). After 10 min, pieces of the skin were cut and further fixed in Bouin's solution for an additional 4 -6 h. Additional samples from the same psoriatic plaques were frozen rapidly in liquid nitrogen and subsequently stored at -80·C until used. Identical procedures werc used for healthy human skin and lichen planus specimcns as normal and pathologic controls.
Western Blotting For Western blotting analysis, aliquots of total protein extracts from normal human skin werc electrophoresed (sodium dodecylsulfate-polyacrylamide gel electrophoresis [SDS-PAGE], 12.5% acrylamide; Fig 1) , blotted on Hybond-ECL nitrocellulose filters (Amcrsham, Bucks, UK), and staincd, using as primary antibody the mousc monoclonal antibcl-2 antibody (Dako, Denmark) as described previously [16] .
Immunohistochemistry and DNA Nick End Labeling Immunohistochcmical staining of human skin was performed using the following as primary antibodies: affinity-purified monospecific IgG raised in rabbits against human red blood cell-soluble tTG (1 : 100), which docs not crossreact with othcr transglutaminases [3, 14] ; monoclonal mouse anti-human oncoprotein bcl-2 (1 : 40) (Dako); spccific anti-human "keratinocyte" transglutarninase (TGI) antibody (1: 100); and anti-human OKT6 and anti -HLA-DR antibodics (1: 50) (Ortho) . Incubations with the primary antibody wcre carried out in a wet chambcr overnight at 4· C. A biotinylated goat anti-rabbit and mouse were used as sccond antibody IgG, followed by a preformed streptavidin-horseradish peroxidase complex (Biogenex). The reaction was developed using aminoethylcarbazole as chromogen substrate and 0.01 % H 2 0 2 • Cells were counterstained in Mayer's hematoxylin. Endogenous peroxidase activity was blocked by methanol-H20 2 • Biopsy specimens were fixed in 4% paraformaldehyde for 15 min at room temperature and then were washed extensively in phosphate-buffered saline. Terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling (TUNEL) was performed as described by Gavrieli et al [20] with few modifications. Endogenous peroxidase was inactivated using 3% H 2 0 2 for 15 min at room temperature; slides then were incubated in terminal deoxynucleotidyl transferase buffcr containing: terminal deoxynucleotidyl transferase (0.5 cU/ml), biotinylatcd-dUTP (0.025 nmol/J.ll), and CoCl 2 (2.5 mM) for 60 min at 37 ·C in a humid atmosphere. The reaction was blocked by transferring the slides to TB buffer (300 mM sodium chloride, 30 mM sodium THE JOURNAL OF INVESTIGATIVE DERMATOLOGY citrate) for 15 min at room temperature. Thc cclls wcre rinsed in distilled watcr, covered with 2% aqucous solution of bovine serum albumin for 10 min, and then immersed in phosphate-buffcred saline for 5 min. The slides were covered with peroxidase-col~ugated streptavidin (BioGenex), incubated for 20 min, and stain cd with aminoethylcarbazole for 10 min.
RESULTS AND DISCUSSION
The morphologic analysis of psoriatic skin revealed many keratinocytes showing chromatin and cytoplasmic condensation typical of cells undergoing apoptosis [4, 5] . To verify whether these morphologic changes were associated with the expression of putative apoptotic genes such as bcl-2 and tTG, we conducted a systematic investigation of their expression in five patients. Proliferation in the epidermis is limited to the basal cell compartment, where a subset of cells, the stem elements, is responsible for maintaining its own number as well as balancing proliferation with cell loss by terminal differentiation [19] . Modification in the rate of terminal differentiation is not involved in the control of skin cell numbers, which instead seem to be regulated by apoptosis [5, 19] . As reported recently [21] , bcl-2 protein was expressed in all cells localized in the basal layer of normal human epidermis (Fig 2) . In contrast, in the psoriatic plaques we noted a drastic reduction in bcl-2 in the proliferative cell compartment, and the protein was present only in a subset of cells showing a spindle-like morphology (compare Fig  2A and 3A) . These bcl-2-positive cells were localized regularly along the basal cell layer and were not stained by the OKT6 and HLA-DR antibodies (Table I ). The absence ofHLA-DR and CD1a expression and their exclusive location in the basal cell compartment and not in the suprabasal layers led us to identify them as melanocytes; by contrast, Langerhans cells normally are spread through the suprabasallayers and usually are positive for HLA-DR and CD1a (Fig 3A; Table I ).
To verify whether bcl-2 down-regulation is typical of psoriasis or is present in other cutaneous disorders involving apoptosis, we investigated its expression in the skin of patients affected by lichen planus (Fig 2) . Immunohistochemical analysis indicated that reduced expression ofbcl-2 also was present in the basal cell compartment of these patients (Fig 2C) . However, in unaffected skin from the same patients, the bcl-2 staining pattern was identical to that found in normal epidermis (Fig 2A,E) . Bcl-2 is considered to be a survival but not a mitogenic factor that is expressed mainly in the stem cell compartments [10,11,21 ,22] . In keeping with this, the drastic reduction in the number of bcl-2 -positive cells observed in the basal layer of psoriatic epidermis suggests the involvement of undifferentiated keratinocytes in the disease.
To substantiate this hypothesis further, we investigated the localization of tTG protein in psoriatic patients (Fig 3B.D) . In normal epidermis, the reaction with the tTG antibody was limited to a few scattered cells showing apoptotic morphology and to the endothelial cells in the dermis (Table I ). In contrast, in all psoriatic patients studied, intense staining was detected in the upper epidermal cell layers (Fig 3B.D) . The reaction with the tTG antibody was particularly intense in cells showing the morphologic features of apoptosis (Fig 3D) . Similar results were obtained in the lesional skin of lichen planus (Fig 2D) , whereas the bcl-2 and tTG staining pattern observed in unaffected skin from psoriatic patients was identical to that found in normal skin (data not shown).
To confirm the specificity of the tTG staining pattern, we studied the localization of the membrane-bound TGI, which is important in the assembly of cornified envelopes in differentiating keratinocytes [23, 24] . In psoriasis, in contrast with the results for tTG, TGI was localized specifically on the plasma membrane of all suprabasal keratinocytes (Fig 3E) , thus confirming previous observations showing abnormal expression ofTGI in psoriasis [25] . By using the TUNEL staining of DNA breaks, we detected a large number of cells showing chromatin fragmentation throughout all cell layers in psoriatic epidermis (Fig 3F) . Taken together, these findings strongly indicate that in psoriatic lesions, many keratinocytes undergo apoptosis.
In recent studies on human skin development, we demonstrated that the different transglutaminases are expressed in a stage-specific manner during epidermal mo~phogenesi.s. confirming their ~pecific functions [23] . tTG is active III apoptoSlS of relatively undifferentiated keratinocytes. whereas T~I is ~xpressed in th~ terminally differentiated cells of mature epidermis l23.24]. The 1l1tense tTG staining we observed in the keratinocytes localized in the upper layers of the epidermis in both psoriasis and lichen planus strongly suggests that these cells are committed to the apoptotic pathway. In keeping with these findings. the amount ofNIN8-Bis(y-glutamyl)-spermidine cross-link was demonstrated. to. be a?normally higher. in cornified envelopes extracted from psonatlc sk1l1 as compared with normal skin [26] . It is interesting that this polyamine-derived crosslink stabilizes the detergent-insoluble polymers formed in cells undergoing apoptosis [12] . The reduced bcl-2 expression detected in the basal layer of psoriatic skin indicates that this phenomenon originates in the stem cell compartment. It is tempting to speculate that in psoriasis. a large number of apoptotic cells can originate from stern cells prematurely recruited to reenter the cell cycle but programmed to persist in a quiescent Go state. In psoriatic patients. the nu~ber of proliferating versus post-mitotic quiescent cells is largely 1l1creased because of abnormal shortening of the cell cycle [19.21] . Furthermore. psoriatic keratinocytes can be primed to undergo apoptosis by various factors (growth factors. cytokines. etc.) produced by dendritic or immune cells present in the dermis. In agreement with this. psoriatic skin lesions overproduce IL-6 [27] . which recently has been shown to upregulate tTG gene expression [28] .
In conclusion. our results offer new insight into the pathogenesis of psoriasis. suggesting a central role for apoptosis. In psoriasis. as observed in other hyperproliferative syndromes. increased apoptosis could be a homeostatic mechanism to counteract the overproduction of cells [3.13] ' This hypothesis is consistent with the emerging idea that it is not possible to induce proliferation in a cell without activating its potential for apoptosis l29].
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